The expression of the potential TRAIL inhibitors XIAP and cFLIP was higher in the TRAIL-sensitive D2247 cells than the resistant lines, arguing against overexpression of these proteins as a mechanism of resistance in gliomas that survived incubation with TRAIL. Here, CFLAR is linked to central nervous system cancer.